Late corneal perforation after photorefractive keratectomy associated with topical diclofenac: involvement of matrix metalloproteinases

Ophthalmology. 2003 Aug;110(8):1626-31. doi: 10.1016/S0161-6420(03)00486-X.

Abstract

Objective: To report a case of a 50-year-old man who was initially seen with a corneal perforation in his right eye 2 months after a photorefractive keratectomy (PRK) procedure and to discuss the roles of topical diclofenac and matrix metalloproteinases (MMPs).

Design: Case report with tissue analysis.

Main outcome measures: Ocular examination, diagnostic workup, surgical treatment, and histologic, immunofluorescent, zymography, and real time-polymerase chain reaction studies on corneal button.

Results: Slit-lamp examination of the right eye revealed a 4-mm diameter area of central corneal thinning with a 2-mm diameter perforation at its center. Predisposing factors included prolonged postoperative topical diclofenac therapy for more than 2 months and a 10-year history of well-controlled diabetes mellitus. An extensive diagnostic workup ruled out a systemic autoimmune disease. A penetrating keratoplasty was performed. Results of immunohistochemical studies of the corneal button showed stromal accumulation of temporary type III and IV collagens, MMP-3, and MMP-9 in the anterior wounded stroma and MMP-9 in the basal corneal epithelial cells of the leading edge. Differential activity and expression of MMP-2 and MMP-9 were found between the central and peripheral corneal buttons.

Conclusions: Prolonged use of diclofenac and diabetes mellitus might be responsible for the corneal perforation after PRK in our patient. MMP-9 and MMP-3 might be involved in delayed wound closure and corneal melting.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Collagen Type III / metabolism
  • Collagen Type IV / metabolism
  • Corneal Diseases / chemically induced*
  • Corneal Diseases / enzymology*
  • Corneal Diseases / pathology
  • Corneal Diseases / surgery
  • Corneal Stroma / drug effects
  • Corneal Stroma / enzymology
  • Corneal Stroma / pathology
  • Diclofenac / adverse effects*
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Keratoplasty, Penetrating
  • Lasers, Excimer
  • Male
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism*
  • Middle Aged
  • Photorefractive Keratectomy*
  • Postoperative Complications*
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Collagen Type III
  • Collagen Type IV
  • RNA, Messenger
  • Diclofenac
  • Matrix Metalloproteinases